Moving the Target on the Optimal Adjuvant Strategy for Resected Pancreatic Cancers: A Systematic Review with Meta-Analysis

Combination regimens have shown superiority over single agents in the adjuvant treatment of resected pancreatic cancer (PC), but there are no data supporting definition of the best regimen. This work aimed to compare the efficacy and safety of mFOLFIRINOX, gemcitabine+capecitabine, and gemcitabine+n...

Descripción completa

Detalles Bibliográficos
Autores principales: Galvano, Antonio, Castiglia, Marta, Rizzo, Sergio, Silvestris, Nicola, Brunetti, Oronzo, Vaccaro, Giovanni, Gristina, Valerio, Barraco, Nadia, Bono, Marco, Guercio, Giovanni, Graceffa, Giuseppa, Fulfaro, Fabio, Gori, Stefania, Bazan, Viviana, Russo, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139837/
https://www.ncbi.nlm.nih.gov/pubmed/32110977
http://dx.doi.org/10.3390/cancers12030534

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139837/
https://www.ncbi.nlm.nih.gov/pubmed/32110977
http://dx.doi.org/10.3390/cancers12030534

Ejemplares similares